JAK inhibitors and ankylosing spondylitis

Ankylosing spondylitis can cause inflammatory spinal pain, joint stiffness, morning joint stiffness, and reduced range of motion. JAK inhibitors alter signals used by immune cells, so they can affect inflammation beyond one painful joint. A rheumatologist weighs your symptoms, examination, previous treatment, infection history, other conditions, and medicines before discussing this option. It is different from a simple pain reliever and needs planned follow-up.

Take the prescribed dose consistently and do not share tablets or change the schedule without medical advice. Tell your clinician about infections, fever, new cough, shingles exposure, blood-clot history, heart or blood-vessel disease, smoking, pregnancy plans, and all medicines or supplements. Blood tests and other checks may be arranged. A plan can also include anti-inflammatory medication, physiotherapy, exercise therapy, or hydrotherapy to preserve movement.

Seek urgent help for chest pain, sudden breathlessness, coughing blood, one-sided leg swelling, sudden weakness, or a new severe headache. Contact your care team promptly for persistent fever, worsening infection, unusual bruising, or a marked change in symptoms. Do not wait for a routine review when a serious reaction or infection is possible.

Ask why a JAK inhibitor is being considered, what checks are needed before starting, which warning symptoms matter, and how response will be reviewed. Discuss alternatives if it is unsuitable and how to coordinate medication with rehabilitation.